Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Gross Profit: 2013-2020

Historic Gross Profit for Ironwood Pharmaceuticals (IRWD) over the last 5 years, with Dec 2020 value amounting to $115.8 million.

  • Ironwood Pharmaceuticals' Gross Profit rose 0.43% to $115.8 million in Q4 2020 from the same period last year, while for Dec 2020 it was $340.7 million, marking a year-over-year increase of 11.41%. This contributed to the annual value of $386.4 million for FY2020, which is 4.49% down from last year.
  • Per Ironwood Pharmaceuticals' latest filing, its Gross Profit stood at $115.8 million for Q4 2020, which was up 49.01% from $77.7 million recorded in Q1 2020.
  • In the past 5 years, Ironwood Pharmaceuticals' Gross Profit ranged from a high of $115.8 million in Q4 2020 and a low of $31.9 million during Q3 2019.
  • Its 3-year average for Gross Profit is $80.7 million, with a median of $77.4 million in 2018.
  • As far as peak fluctuations go, Ironwood Pharmaceuticals' Gross Profit grew by 28.88% in 2018, and later plummeted by 41.68% in 2019.
  • Over the past 4 years, Ironwood Pharmaceuticals' Gross Profit (Quarterly) stood at $85.2 million in 2017, then grew by 28.17% to $109.2 million in 2018, then climbed by 5.55% to $115.3 million in 2019, then increased by 0.43% to $115.8 million in 2020.
  • Its last three reported values are $115.8 million in Q4 2020, $77.7 million for Q1 2020, and $115.3 million during Q4 2019.